Menu
Back to User profile » Dr Shi-Bing Wang
Papers published by Dr Shi-Bing Wang:
Synergistic Suppression Effect on Tumor Growth of Acute Myeloid Leukemia by Combining Cytarabine with an Engineered Oncolytic Vaccinia Virus [Retraction]
Peng J, Wang S, Fan W, Li S, Wu Y, Mou X, Wang J, Tong X
OncoTargets and Therapy 2022, 15:1119-1120
Published Date: 13 October 2022
Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS)
Zhu L, Xie S, Yang C, Hua N, Wu Y, Wang L, Ni W, Tong X, Fei M, Wang S
Cancer Management and Research 2021, 13:5275-5286
Published Date: 2 July 2021
Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma
Wang P, Wu Y, Yang C, Zhao G, Liu Y, Cheng G, Wang S
OncoTargets and Therapy 2020, 13:1421-1429
Published Date: 17 February 2020
RETRACTED ARTICLE: Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus
Peng J, Wang S, Fan W, Li S, Wu Y, Mou X, Wang J, Tong X
OncoTargets and Therapy 2018, 11:6887-6900
Published Date: 15 October 2018
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus
Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X
OncoTargets and Therapy 2016, 9:6381-6388
Published Date: 17 October 2016
High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis
Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ
OncoTargets and Therapy 2016, 9:3595-3602
Published Date: 16 June 2016